Three EGFR mutations in our study were rare mutations, in contrast to previous studies that reported lower TMB in EGFR-mutant lung cancer compared with EGFR wild-type (49), we found TMB in EGFR-mutant patients was higher in our study, which might be associated with mutation type and the signature of SHC. This evidence concerns the gene EGFR and lung cancer.